- Methodology article
- Open Access
Development of a new bicistronic retroviral vector with strong IRES activity
© Martin et al; licensee BioMed Central Ltd. 2006
Received: 15 August 2005
Accepted: 12 January 2006
Published: 12 January 2006
Internal Ribosome Entry Site (IRES)-based bicistronic vectors are important tools in today's cell biology. Among applications, the expression of two proteins under the control of a unique promoter permits the monitoring of expression of a protein whose biological function is being investigated through the observation of an easily detectable tracer, such as Green Fluorescent Protein (GFP). However, analysis of published results making use of bicistronic vectors indicates that the efficiency of the IRES-controlled expression can vary widely from one vector to another, despite their apparent identical IRES sequences. We investigated the molecular basis for these discrepancies.
We observed up to a 10 fold difference in IRES-controlled expression from distinct bicistronic expression vectors harboring the same apparent IRES sequences. We show that the insertion of a HindIII site, in place of the initiating AUG codon of the wild type EMCV IRES, is responsible for the dramatic loss of expression from the second cistron, whereas expression from the first cistron remains unaffected. Thus, while the replacement of the authentic viral initiating AUG by a HindIII site results in the theoretical usage of the initiation codon of the HindIII-subcloned cDNA, the subsequent drop of expression dramatically diminishes the interest of the bicistronic structure. Indeed, insertion of the HindIII site has such a negative effect on IRES function that detection of the IRES-controlled product can be difficult, and sometimes even below the levels of detection. It is striking to observe that this deleterious modification is widely found in available IRES-containing vectors, including commercial ones, despite early reports in the literature stating the importance of the integrity of the initiation codon for optimal IRES function.
From these observations, we engineered a new vector family, pPRIG, which respects the EMCV IRES structure, and permits easy cloning, tagging, sequencing, and expression of any cDNA in the first cistron, while keeping a high level of expression from its IRES-dependent second cistron (here encoding eGFP).
Expressing two distinct coding sequences under the control of a unique promoter is of great interest to molecular and cellular biologists. Since both proteins are under the control of the same promoter, detection of the product encoded by the second cistron is the insurance that the first cistron is also being expressed. One can take advantage of bicistronic expression to select clones based on a resistance encoded by the second cistron , as well as sorting cells upon their GFP expression status. Polycistronic expression is also of potentially great interest when simultaneous expression of two different proteins is required for development of new gene therapy approaches . Several commercially available bicistronic vectors are based on the Internal Ribosome Entry Site (IRES) from the Encephalomyocarditis virus (EMCV), in which the AUG has been modified to a HindIII site. This modification facilitates the cloning of the IRES-controlled cDNA, and insures that the initiation codon stems from the coding sequence inserted downstream of this cloning site. This avoids the N-terminal addition of amino acids derived from the junction of the IRES to the coding sequence of interest. However, previously published observations [3, 4] demonstrated that this AUG is actually the most efficiently recognized by the translation machinery in the EMCV IRES. We compared the expression of a full-length cDNA cloned either in the HindIII-modified EMCV IRES (the ATG initiation codon being that of the cDNA), or downstream of the original unmodified EMCV initiation codon (which is then used as the initiation codon). We observed that expression of the second cistron in the HindIII-modified vectors can be as much as 10 fold lower than the expression of the same cistron whose translation initiates at the original, non-modified EMCV initiation codon.
In view of this dramatic decrease of IRES activity, we developed a new and convenient set of eukaryotic bicistronic expression vectors that respects the original EMCV initiation environment and fulfills several important needs: ease of cloning, sequencing possibilities of the cloned inserts using universal primers, high level of plasmid DNA production, possibility of epitope tagging for immunological tracking of expressed inserts, possibility of production of retroviral particles for retroviral transduction, and easy monitoring of expression through the concomitant synthesis of a fluorescent protein (GFP).
Selection of an optimal IRES sequence
293T cells were transfected with the same amount of the different vector DNAs, and were subsequently subjected to FACS analysis. As indicated in Table 1, fluorescence intensity was reproducibly much weaker from the HindIII-modified IRES (pMigR-Hd) compared to the expression from its wild type counterpart (pMigR-ATG) or the original pMigR, despite that in both cases their transcription originated from the same LTR promoters. The HindIII-modification of the EMCV IRES Initiation codon, in agreement with early reports on its structure and function , is thus responsible for an over 10 fold decrease in expression (14 versus 234 peak values). A similar analysis, performed with the same vectors containing an additional cDNA cloned into the first cistron (pMigR-Hd-BAZF and pMigR-ATG-BAZF), gave very similar results (Table 1). This confirms that the difference in the efficiency of expression of the second cistron is solely the result of differences in the IRES AUG initiation codon flanking sequences. The proportion of GFP positive cells is comparable in all cases, indicating that the strong difference of peak values is not due to differences in transfection efficiency.
Altogether, these experiments confirm that the integrity of the initiating AUG of the EMCV IRES is absolutely required for optimal activity, and that the modification brought by the creation of a HindIII site results in a severe loss of protein expression. It thus appears that when a high expression of the IRES-controlled cistron is needed, one should verify the integrity of the EMCV IRES present in the expression vector used, and shift to a vector containing the wild type form of the EMCV IRES.
Engineering of a new and convenient retroviral IRES- containing vector, pPRIG
In order to palliate the problems stemming from the use of HindIII-modified IRES-containing expression vectors, we set up to develop a new vector that would permit i) easy directional cloning and sequencing of most inserts; ii) possible HA-tagging of the expressed proteins; iii) easy detection of the transduced cells through high expression of the IRES-controlled eGFPand iv) production of retroviral particles if needed. We called this new vector series pPRIG, for plasmid Polylinker Retroviral IRES GFP.
Bidirectional polylinker design
Cfr9I (SmaI**)/BspMII/BetI/Cfr10I/NgoAIV (NaeI**)/SgrAI
Cfr9I (SmaI**)/AgeI/BetI/Cfr10I/NgoAIV (NaeI**)/SgrAI
Direct sequencing with T7 and SP6primers
Flanking of the polylinker with T7 and SP6 universal primer sites makes sequencing of any insert straightforward. Our vectors are simultaneously cloning, expression and proviral vectors therefore no additional subcloning into other vectors is required. Sequencing of the insert of interest with T7 and SP6 primers allows for the verification of the integrity of the insert as well as the coherence of the coding frame following in vitro transcription/translation. Amplification of the plasmid is all that is needed to obtain material for functional assays in cells. The backbone of the vectors is derived from the pUC vector series, which insures a high DNA yield during plasmid amplification. We routinely obtained production of at least 5 mg/l of culture medium (LB-50 μg/ml Ampicillin) with all of our constructs, reaching up to 20 mg/l with some, as well as with the empty vectors. The production differences observed are likely to reflect the impact of the cloned inserts on plasmid amplification.
Transfection efficiency remains one of the most severe limitations in the functional analysis of exogenously expressed cDNAs. This is why we chose to build the pPRIG vector on a retroviral backbone, which allows for the production of viral particles when needed, in order to obtain a high percentage of expressing cells. As a starting backbone for our pPRIG constructs, we used the pAP2 construct, which was kindly provided to us by Dr. J. Galipeau . This construct contains a CMV promoter, which efficiently drives the expression of the bicistronic RNA following transfection in cells and which is replaced by an LTR when used in a retroviral context, due to the 3' LTR duplication upon reverse transcription.
Extensive research over the last 15 years has led to significant advances in deciphering the molecular mechanisms involved in IRES function. All studies pointed to the involvement of secondary structures in the recognition of functional ribosome entry sites, as well as the importance of the distance between the polypyrimidine track and the actual initiating AUG. In the case of the Encephalomyocarditis virus-derived IRES, the second AUG located 22 nucleotides downstream of the UUUCC sequence, present in the polypyrimidine-rich track at the 3' of the IRES, has been identified as the authentic viral initiation codon [3, 4, 7]. Some reports indicated that insertion of a spacer up to 95 nucleotides between the 3' end of the IRES and the ORF of interest was not deleterious to the second cistron expression, provided that no secondary structure or out of frame initiation codon were present within that spacer . Several constructs have been subsequently developed in which the original AUG (gat gat aat ATG gcc aca) was modified to a HindIII site (gat gat AAGCTT gcc aca), with the idea that cloning of a cDNA in this HindIII site would result in a further scanning of the ribosomes down to the AUG found in the cloned cDNA where initiation would occur. In this report we showed that despite its popularity among scientists wishing to use an IRES-containing expression vector, this modification present in many commercial vectors actually results in a dramatic decrease in the expression of the IRES-controlled coding sequence as compared to that observed with the wild type IRES. Earlier studies demonstrating that the EMCV IRES possesses a scanning independent fixed location AUG , together with the observations reported here, clearly support that the translational initiation is much more efficient from the natural (non mutated) IRES than from a HindIII mutated counterpart. This confirms that the IRES and the initiation codon are not completely independent modules that can be freely separated and remixed with heterologous sequences, as is often done. In our studies, we used the eGFP sequence as a reporter, whose initiator AUG is located 12 bases downstream of the engineered HindIII site (Table 1). Such a short distance is nevertheless sufficient to greatly affect the eGFP expression, despite the conservation of the optimal eGFP AUG context (acc AUG gug). Indeed, FACS analyses indicated a more than 10 fold difference in eGFP peak intensity. In addition, Western blot analysis of eGFP expression following viral transduction using HindIII-modified vectors displayed a weak eGFP signal, whereas wild type IRES resulted in a strong eGFP signal. As a control, both wild type and HindIII-modified constructs expressed HA-DsRed protein independent of the different IRESes, and comparable amounts of HA-DsRed were detected by Western blot analysis. In view of these results, we constructed a new vector family that allows for a wide range of applications, while keeping a strong IRES-dependent expression. This vector series has been called pPRIG, for plasmid Polylinker Retroviral IRESGFP. Due to a newly designed type of polylinker, directional cloning of a wide range of inserts is greatly facilitated, and HA-tagging of the insert of interest is possible if needed, depending upon which pPRIG vector is selected. Furthermore, the presence of T7 and SP6 primer sequences renders the sequencing of the cloned inserts straightforward, while allowing for the verification of insert expression via in vitro transcription/translation. Finally, our vectors are built on a retroviral backbone, allowing highly efficient cell transduction if needed. These vectors will be made freely available to the scientific community upon request.
A survey of commonly used EMCV IRES-derived bicistronic vectors indicated that many of them, including several commercial ones, have their 11th AUG modified to a HindIII site. In this work we confirm previous results demonstrating that the EMCV IRES predominant AUG (11th) cannot be modified without strongly affecting the overall efficiency of the IRES-dependent expression. Consequently, we show that all HindIII modified bicistronic vectors are very ineffective for their IRES-dependent expression. We developed a new family of expression vectors, called pPRIG, in which the structure of the EMCV IRES is left untouched. We verified that the IRES-dependent eGFP expression is much stronger than the HindIII modified IRES, and remains strong for weeks, even in a retroviral context. The pPRIG also contains a new type of polylinker that allows bidirectional cloning. In addition, this vector family permits easy HA-tagging, sequencing and in vitro expression of the insert, as well as the production of retroviral particles if needed.
All constructs were made using classical molecular biology techniques, as described in . A detailed construct strategy is available upon request, but briefly, the four pPRIG vectors were constructed as follows. The pPRIG-Hd-HA vectors were constructed from the pAP2-IRESeGFP, provided by Dr. J. Galipeau . The EcoRI, NotI, PvuII, SalI, SphI, SseI restriction sites were removed from the vector in order to include them in a newly developed Multiple Cloning Site (MCS). A sequence encompassing a T7 bacterial promoter and an HA tag (followed by BamHI and EcoRI sites) was inserted between the end of delta-gag and the beginning of the IRES. Double stranded oligonucleotides containing the MCS were inserted between the BamHI and EcoRI sites. Three sets of oligonucleotides were used to create the three HA tags, each one being in a different frame as compared to the MCS, giving rise to pPRIG-Hind-HA 1, 2 and 3. The pPRIG-Hd was obtained by deleting the HA tag sequence after digestion with NgoAIV and BamHI, filling in with the Klenow polymerase and religation (the BamHI site is recovered in this process). All vectors from the pPRIG series are identical to the pPRIG-Hd vectors, except for the presence of the wild type EMCV IRES initiation codon in place of the HindIII site.
The pMigR vector  is similar to the pAP2-IRESeGFP yet differs in the following manner. The CMV promoter is replaced by an LTR. There are a few punctual differences in sequences in the LTRs as compared to the pAP2-IRESeGFP 3' LTR. The IRES sequence has conserved the 3' initiating AUG, which is mutated in the pAP2-IRESeGFP vector to generate a HindIII site. The eGFP polypeptide starts with its own AUG in the pAP2-IRESeGFP vector, while it is in frame with the IRES 3' AUG in the pMigR vector.
The pMigR-Hd, containing the pPRIG-Hd-HA-MCS and IRES (ATG mutated to generate a HindIII), was obtained by replacing the SpeI-NcoI fragment of the pMigR vector by the corresponding one from the pPRIG-Hd-HA. The pMigR-ATG, containing the pPRIG-Hd-HA MCS and the pMigR IRES (wt EMCV sequence retaining the 3' IRES ATG), was obtained by replacing the SpeI-DraIII of the pMigR by the corresponding SpeI/DraIII fragment from the pPRIG-HA vectors.
The EcoRI/Bsp120 I fragment of the pcDNA-BAZF vector encoding the mouse BAZF cDNA  was cloned at the EcoRI/NotI sites of the MigR-pAP7 HinDIII and MigR-pAP7 ATG vectors. The mouse AES (also known as GRG5) cDNA  containing the entire open reading frame was synthetized by PCR using retrotranscribed GS2 embryonic stem cell mRNA as templates. The PCR product (a gift from Dr D. Sekkaï) containing a 5' Xho I and a 3' EcoRI site brought by the primers, was cloned into the pDrive vector (Qiagen), verified by sequencing, and then cloned into the Xho I/Mfe I sites of the MigR-pAP7 HinDIII and MigR-pAP7-ATG vectors.
pPRIG-Hd-HA-Red, pPRIG-HA-Red and pAP2-HA-Red were obtained as follows. For, pPRIG-Hd-HA-Red and pPRIG-HA-Red, the BamHI-NotI fragment from pDsRED-N1 was cloned into pRIG-Hd-HA2 and pPRIG-HA2, respectively, digested with the same restriction enzymes. For pAP2-HA-Red, the NgoAIV-AccI fragment from pRIG-HA-Red was cloned into BBg (a derivative of pBluescript SKII containing a BglII site) digested with XmaI-AccI to give the BBg HA-Red from which the BglII -XhoI fragment (coding for the HA-DsRed fusion polypeptide) was purified and recloned into the pAP2-IRESeGFP vector opened by BglII and XhoI.
HEK 293T cells were grown in DMEM supplemented with 10% FCS. Cells were seeded at 30–40% confluence in 6 well plates (about 500 000 cells/well), and transfected the following day with 1.6 μg of the different expression vectors. Cells were analyzed between 24 and 72 h post-transfection. For virus production, the different expression vectors were cotransfected with 0.8 μg of pCMV-GagPol and 0.8 μg of pCMV-VSVG helper plasmids. Supernatants were collected 48 h post-transfection, passed through 0.45 μm filters, then added to the exponentially growing REF cultures in the presence of 4 μg/ml of polybrene. The medium was changed 16 h later, and transduced cells were kept in culture and passed 3× every 4 days.
Cells were harvested, lysed and boiled in Laemmli buffer. 1/20 of each lysate was loaded and migrated by SDS-PAGE, and analysed by Western blotting. The membranes were incubated with F-7 mouse anti-HA antibody (1/500, Santa Cruz) and with rabbit A.v. peptide anti-GFP antibody (1/200, Clontech), followed by a peroxydase-coupled anti-mouse or anti-rabbit antibody, respectively. The signals were revealed by chemiluminescence.
48 h post- transfection, HEK 293T cells were rinsed and harvested in PBS, then analysed for GFP expression by flow cytometry using a Facscan (Becton Dickinson). 10000 events were recorded.
We thank Dr. Jacques Galipeau for kindly providing us with his pAP2 construct and Sébastien Giroux for help with FACS analyses. This work was made possible by funding from CNRS, INSERM and Proskelia.
- Chambard JC, Pognonec P: A reliable way of obtaining stable inducible clones. Nucleic Acids Res. 1998, 26: 3443-3444. 10.1093/nar/26.14.3443.View ArticleGoogle Scholar
- Ngoi SM, Chien AC, Lee CG: Exploiting internal ribosome entry sites in gene therapy vector design. Curr Gene Ther. 2004, 4: 15-31. 10.2174/1566523044578095.View ArticleGoogle Scholar
- Jang SK, Wimmer E: Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev. 1990, 4: 1560-1572.View ArticleGoogle Scholar
- Ohlmann T, Jackson RJ: The properties of chimeric picornavirus IRESes show that discrimination between internal translation initiation sites is influenced by the identity of the IRES and not just the context of the AUG codon. Rna. 1999, 5: 764-778. 10.1017/S1355838299982158.View ArticleGoogle Scholar
- Galipeau J, Li H, Paquin A, Sicilia F, Karpati G, Nalbantoglu J: Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer. Cancer Res. 1999, 59: 2384-2394.Google Scholar
- Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D: Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood. 1998, 92: 3780-3792.Google Scholar
- Kaminski A, Belsham GJ, Jackson RJ: Translation of encephalomyocarditis virus RNA: parameters influencing the selection of the internal initiation site. Embo J. 1994, 13: 1673-1681.Google Scholar
- Lopez de Quinto S, Martinez-Salas E: Parameters influencing translational efficiency in aphthovirus IRES-based bicistronic expression vectors. Gene. 1998, 217: 51-56. 10.1016/S0378-1119(98)00379-5.View ArticleGoogle Scholar
- Sambrook J, Russell DW: Molecular Cloning: A Laboratory Manual. 2001, Cold Spring Harbor Laboratory PressGoogle Scholar
- Okabe S, Fukuda T, Ishibashi K, Kojima S, Okada S, Hatano M, Ebara M, Saisho H, Tokuhisa T: BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor. Mol Cell Biol. 1998, 18: 4235-4244.View ArticleGoogle Scholar
- Fisher AL, Caudy M: Groucho proteins: transcriptional corepressors for specific subsets of DNA-binding transcription factors in vertebrates and invertebrates. Genes Dev. 1998, 12: 1931-1940.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.